Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDImmuneering Corp Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | -$0.26 | -$0.25 | -$0.26 |
| Q2 2026 | 5 | -$0.32 | -$0.28 | -$0.30 |
| Q3 2026 | 5 | -$0.37 | -$0.30 | -$0.34 |
| Q1 2027 | 3 | -$0.34 | -$0.34 | -$0.34 |
| Q2 2027 | 3 | -$0.37 | -$0.37 | -$0.37 |
| Q3 2027 | 3 | -$0.39 | -$0.39 | -$0.39 |
| Q4 2027 | 3 | -$0.40 | -$0.40 | -$0.40 |
Immuneering Corp Earnings Date And Information
Immuneering Corp last posted its earnings results on Wednesday, August 5th, 2026. The company reported $-0.27 earnings per share for the quarter, missing analysts' consensus estimates of $-0.26429 by $0.00571. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Immuneering Corp has generated $-1 earnings per share over the last year ($-1.27 diluted earnings per share) and currently has a price-to-earnings ratio of -5.1. Immuneering Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Immuneering Corp Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/05/2026 | Q2 2026 | -$0.26 | -$0.27 | -0.01 | $0 | $0 |
| 05/15/2026 | Q1 2026 | -$0.30 | -$0.21 | 0.09 | N/A | $0 |
| 03/06/2026 | Q4 2025 | -$0.31 | -$0.18 | 0.13 | N/A | $0 |
| 11/12/2025 | Q3 2025 | -$0.37 | -$0.38 | -0.01 | N/A | $0 |
| 08/13/2025 | Q2 2025 | -$0.40 | -$0.40 | 0 | N/A | $0 |
| 05/05/2025 | Q1 2025 | -$0.41 | -$0.42 | -0.01 | N/A | $0 |
| 03/20/2025 | Q4 2024 | -$0.42 | -$0.58 | -0.16 | N/A | $0 |
| 11/13/2024 | Q3 2024 | -$0.54 | -$0.49 | 0.05 | N/A | $0 |
| 08/06/2024 | Q2 2024 | -$0.51 | -$0.47 | 0.04 | N/A | $0 |
| 05/07/2024 | Q1 2024 | -$0.45 | -$0.49 | -0.04 | N/A | $0 |
| 03/01/2024 | Q4 2023 | -$0.48 | -$0.52 | -0.04 | N/A | $0 |
| 11/09/2023 | Q3 2023 | -$0.51 | -$0.43 | 0.08 | N/A | $0 |
| 08/03/2023 | Q2 2023 | -$0.54 | -$0.43 | 0.11 | N/A | $0 |
| 05/04/2023 | Q1 2023 | -$0.54 | -$0.51 | 0.03 | $8.33 K | $0 |
| 03/06/2023 | Q4 2022 | -$0.58 | -$0.47 | 0.11 | $60.00 K | $455 |
| 11/10/2022 | Q3 2022 | -$0.48 | -$0.47 | 0.01 | $153.33 K | $38.38 K |
| 08/10/2022 | Q2 2022 | -$0.52 | -$0.44 | 0.08 | $196.80 K | $94.42 K |
| 05/10/2022 | Q1 2022 | -$0.44 | -$0.49 | -0.05 | $182.00 K | $183.70 K |
| 03/10/2022 | Q4 2021 | -$0.39 | -$0.42 | -0.03 | $535.50 K | $189.59 K |
| 11/09/2021 | Q3 2021 | -$0.61 | -$0.47 | 0.14 | $700.00 K | $482.13 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Immuneering Corp Earnings: FAQ's
The conference call for Immuneering Corp's latest earnings report can be listened to online.
The conference call transcript for Immuneering Corp's latest earnings report can be read online.
Immuneering Corp (:IMRX) has a recorded net income of $-56,024,898.Immuneering Corp has generated $-1.27 earnings per share over the last four quarters.
Immuneering Corp (:IMRX) has a price-to-earnings ratio of -5.1 and price/earnings-to-growth ratio is -0.08.